Sagent Pharmaceuticals, Inc. 4
4 · Sagent Pharmaceuticals, Inc. · Filed Aug 31, 2016
Insider Transaction Report
Form 4
Behrens Mary Taylor
Director
Transactions
- Disposition to Issuer
Stock Option to Buy
2016-08-29$10.15/sh−6,379$64,747→ 0 totalExercise: $11.60Exp: 2020-12-02→ Common Stock (6,379 underlying) - Disposition from Tender
Common Stock
2016-08-29$21.75/sh−7,097$154,360→ 0 total - Disposition to Issuer
Restricted Stock Units
2016-08-29$21.75/sh−691$15,029→ 0 total→ Common Stock (691 underlying) - Disposition to Issuer
Restricted Stock Units
2016-08-29$21.75/sh−8,556$186,093→ 0 total→ Common Stock (8,556 underlying) - Disposition to Issuer
Restricted Stock Units
2016-08-29$21.75/sh−1,381$30,037→ 0 total→ Common Stock (1,381 underlying) - Disposition to Issuer
Restricted Stock Units
2016-08-29$21.75/sh−1,860$40,455→ 0 total→ Common Stock (1,860 underlying) - Disposition to Issuer
Restricted Stock Units
2016-08-29$21.75/sh−760$16,530→ 0 total→ Common Stock (760 underlying)
Footnotes (9)
- [F1]Pursuant to the Agreement and Plan of Merger by and among Nichi-Iko Pharmaceutical Co. Ltd., Shepard Vision, Inc. and Sagent Pharmaceuticals, Inc. (the "Merger Agreement"), these shares were disposed of in a cash tender offer by Shepard Vision, Inc. to acquire common stock of Sagent Pharmaceuticals, Inc. in exchange for $21.75 per share in cash, without interest, less any applicable withholding taxes (the "Consideration").
- [F2]Each restricted stock unit represents a contingent right to receive one share of SGNT common stock.
- [F3]The restricted stock units provided for vesting on February 22, 2017.
- [F4]Each restricted stock unit was disposed pursuant to the Merger Agreement whereby each such restricted stock unit was cancelled and converted into the right to receive the Consideration.
- [F5]The restricted stock units provided for vesting in four equal annual installments beginning on April 9, 2016.
- [F6]The restricted stock units provided for vesting in four equal annual installments beginning on February 25, 2016.
- [F7]The restricted stock units provided for vesting in four equal annual installments beginning on February 18, 2015.
- [F8]The restricted stock units provided for vesting in four equal annual installments beginning on February 21, 2014.
- [F9]Represents the disposition of options, which provided for vesting in four equal installments beginning December 2, 2011. The options were cancelled pursuant to the Merger Agreement in exchange for a cash payment of $10.15 per share subject to the option. This per share price represents the difference between the applicable exercise price of the option and the Consideration.